Dr. Kariann Abbate, MD

Dr. Abbate practices at The Valley Hospital in Paramus, New Jersey, part of Valley Health System.

Dr. Abbate's NPI, 1548429582, was assigned on June 5, 2008. Dr. Abbate graduated from Sidney Kimmel Medical College in 2007. Dr. Abbate holds New Jersey license 25MA09575400.

Dr. Abbate's primary practice is The Valley Hospital, at 4 Valley Health Plaza, Paramus, NJ 07652 in Bergen County. The practice phone is (201) 447-8000.

Dr. Abbate's primary practice is The Valley Hospital in Paramus, New Jersey, part of Valley Health System. Dr. Abbate is also affiliated with Hackensack University Medical Center. The medical group on file is Valley Medical Group. Dmand AI also links Dr. Abbate to 1 more group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abbate practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Abbate's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Abbate is board certified in advanced heart failure and transplant cardiology by the American Board of Internal Medicine. Dmand AI has Dr. Abbate's licenses on file in 3 states: New Jersey, New York and Pennsylvania.

Dmand AI lists cardiomyopathy and heart failure among the conditions Dr. Abbate treats.

CMS data shows 1,908 Medicare services from Dr. Abbate across 14 procedure codes in 2024, for 711 Medicare patients. Medicare paid $154,203 for them.

CMS counts 711 Medicare patients who saw Dr. Abbate in 2024. The largest group is 75 to 84, with 278 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 2.27, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abbate's median patient age at 77, with 43% women.

In 2024, Dr. Abbate wrote 5,028 Medicare Part D claims for 581 patients. 61% of them were for generic drugs. CMS names the drug for 4,656 of them, across 55 drugs with 11 or more claims each, at $11,495,966 in total drug cost. In 2023, CMS named 4,023 claims across 45 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Abbate for performance year 2024, reported through an alternative payment model (APM). Dr. Abbate accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Abbate as offering telehealth.

Dmand AI links 3 papers to Dr. Abbate in 2013. 2013 was the busiest year, with 2. The most frequent topics are Heart Failure. Dr. Abbate's most frequent co-author is Efstathia Andrikopoulou.

Dmand AI links Dr. Abbate to 2 clinical trials. Conditions studied include Anemia, Iron-Deficiency, Heart Failure and Anemia, Hypochromic.

CMS Open Payments shows 240 general payments to Dr. Abbate from 24 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 78% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $38,539.

Dr. Abbate graduated from Sidney Kimmel Medical College in 2007. Dr. Abbate is a member of ACC.

Dr. Abbate is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.